BM&FBOVESPA to acquire additional 3.2% stake in CME Group - MarketLine Financial Deals

BM&FBOVESPA to acquire additional 3.2% stake in CME Group

BM&FBOVESPA to acquire additional 3.2% stake in CME Group - MarketLine Financial Deals
BM&FBOVESPA to acquire additional 3.2% stake in CME Group
Published Feb 11, 2010
3 pages — Published Feb 11, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

BM&FBOVESPA SA has agreed to acquire an additional 3.2% stake in CME Group, Inc., a US-based a financial exchange operator.

  
Source:
Document ID
MA19634_100218
Country
Country
Ticker
BVMF3=BR
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "BM&FBOVESPA to acquire additional 3.2% stake in CME Group" Feb 11, 2010. Alacra Store. Dec 10, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/BM-FBOVESPA-to-acquire-additional-3-2-stake-in-CME-Group-2052-24268>
  
APA:
MarketLine Financial Deals. (2010). BM&FBOVESPA to acquire additional 3.2% stake in CME Group Feb 11, 2010. New York, NY: Alacra Store. Retrieved Dec 10, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/BM-FBOVESPA-to-acquire-additional-3-2-stake-in-CME-Group-2052-24268>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.